日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Atezolizumab plus Bevacizumab with Transcatheter Arterial Chemoembolization (Sandwich Strategy) versus Atezolizumab plus Bevacizumab Alone in Hepatocellular Carcinoma: A Multicenter Retrospective Study

阿特珠单抗联合贝伐珠单抗经导管动脉化疗栓塞术（三明治策略）与阿特珠单抗单药联合贝伐珠单抗治疗肝细胞癌的疗效比较：一项多中心回顾性研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000549979
Hashimoto, Ko; Kawaoka, Tomokazu; Emori, Tomoaki; Tanaka, Aiko; Shirane, Yuki; Miura, Ryoichi; Fujii, Yasutoshi; Nakahara, Hikaru; Yamaoka, Kenji; Uchikawa, Shinsuke; Fujino, Hatsue; Ono, Atsushi; Murakami, Eisuke; Miki, Daiki; Hayes, C Nelson; Hiramatsu, Akira; Amioka, Kei; Nonaka, Michihiro; Aisaka, Yasuyuki; Morio, Kei; Moriya, Takashi; Teraoka, Yuji; Kono, Hirotaka; Suehiro, Yosuke; Masaki, Keiichi; Ohya, Kazuki; Takaki, Shintaro; Mori, Nami; Tsuji, Keiji; Kosaka, Yumi; Nakahara, Takashi; Aikata, Hiroshi; Tsuge, Masataka; Oka, Shiro
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice

携带前核心区和基础核心启动子突变的乙型肝炎病毒（HBV）表现出高复制表型，并在人源化肝嵌合小鼠中引起内质网应激介导的细胞死亡。

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000335
Uchida, Takuro; Imamura, Michio; Hayes, C Nelson; Suehiro, Yosuke; Teraoka, Yuji; Ohya, Kazuki; Aikata, Hiroshi; Abe-Chayama, Hiromi; Ishida, Yuji; Tateno, Chise; Hara, Yuichi; Hino, Keisuke; Okamoto, Toru; Matsuura, Yoshiharu; Aizaki, Hideki; Wake, Kenjiro; Kohara, Michinori; Liang, T Jake; Oka, Shiro; Chayama, Kazuaki
微生物学
细胞生物学
肝炎
内质网应激
发表日期：2023
文献求助 收藏

Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures

鲁苏曲波帕治疗计划接受侵入性手术的慢性肝病患者血小板减少症的疗效

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.5930-20
Nishida, Yuno; Kawaoka, Tomokazu; Imamura, Michio; Namba, Maiko; Fujii, Yasutoshi; Uchikawa, Shinsuke; Ohya, Kazuki; Daijo, Kana; Teraoka, Yuji; Morio, Kei; Fujino, Hatsue; Nakahara, Takashi; Yamauchi, Masami; Hiramatsu, Akira; Tsuge, Masataka; Aikata, Hiroshi; Takahashi, Shoichi; Hayes, C Nelson; Fukuhara, Takayuki; Tsuji, Keiji; Arataki, Keiko; Nagaoki, Yuko; Aisaka, Yasuyuki; Kamada, Koji; Kodama, Hideaki; Chayama, Kazuaki
血小板
发表日期：2021
文献求助 收藏

Circulating cytokines and angiogenic factors based signature associated with the relative dose intensity during treatment in patients with advanced hepatocellular carcinoma receiving lenvatinib.

循环细胞因子和血管生成因子特征与接受乐伐替尼治疗的晚期肝细胞癌患者在治疗期间的相对剂量强度相关

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/1758835920922051
Ono Atsushi, Aikata Hiroshi, Yamauchi Masami, Kodama Kenichiro, Ohishi Waka, Kishi Takeshi, Ohya Kazuki, Teraoka Yuji, Osawa Mitsutaka, Fujino Hatsue, Nakahara Takashi, Murakami Eisuke, Miki Daiki, Kawaoka Tomokazu, Abe-Chayama Hiromi, Zhang Peiyi, Liu Songyao, Makokha Grace Naswa, Tsuge Masataka, Imamura Michio, Hayes C Nelson, Chayama Kazuaki
细胞生物学
血管生成
发表日期：2020
文献求助 收藏

Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer

晚期乳腺癌患者接受曲妥珠单抗-美坦新（T-DM1）治疗后出现窦状隙阻塞综合征

期刊:International Cancer Conference Journal
影响因子:0.5
doi:10.1007/s13691-019-00392-4
Fujii, Yasutoshi; Doi, Mihoko; Tsukiyama, Naofumi; Hattori, Yui; Ohya, Kazuki; Shiroma, Noriyuki; Morio, Kei; Morioka, Takehiko; Aikata, Hiroshi; Shinozaki, Katsunori; Chayama, Kazuaki
肿瘤
肿瘤免疫
乳腺癌
发表日期：2020
文献求助 收藏

Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

左卡尼汀的使用与肝硬化患者肌肉减少症的改善相关。

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1309
Hiramatsu, Akira; Aikata, Hiroshi; Uchikawa, Shinsuke; Ohya, Kazuki; Kodama, Kenichiro; Nishida, Yuno; Daijo, Kana; Osawa, Mitsutaka; Teraoka, Yuji; Honda, Fumi; Inagaki, Yuki; Morio, Kei; Morio, Reona; Fujino, Hatsue; Nakahara, Takashi; Murakami, Eisuke; Yamauchi, Masami; Kawaoka, Tomokazu; Miki, Daiki; Tsuge, Masataka; Imamura, Michio; Tanaka, Junko; Chayama, Kazuaki
肝硬化
发表日期：2019
文献求助 收藏